New functions for PI3K in the control of cell division

Cell Cycle

Volumn 6, Issue 14, 2007, Pages 1696-1698

  Kumar, Amit ^a   Carrera, Ana C ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

c Myc; Cell cycle; Cytokinesis; p85; Phosphoinositide 3 kinase

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4 BISPHOSPHATE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PROTEIN P85;

AUTOIMMUNITY; CANCER; CELL CYCLE G1 PHASE; CELL DIVISION; CELL MUTANT; CELL SURVIVAL; CYTOKINESIS; ENZYME ACTIVITY; NONHUMAN; PROTEIN FUNCTION; REVIEW;

EID: 34548222718     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.6.14.4492     Document Type: Review

References (44)

1. Vanhaesebroeck B, Ali K, Bilancio A, Geering B, Foukas LC. Signalling by PI3K isoforms: Insights from gene-targeted mice. Trends Biochem Sci 2005; 30:194-204.
2. Garcia Z, Kumar A, Marques M, Cortes I, Carrera AC. Phosphoinositide 3-kinase controls early and late events in mammalian cell division. EMBO J 2006; 25:655-61.
3. Jimenez C, Hernandez C, Pimentel B, Carrera AC. The p85 regulatory subunit controls sequential activation of phosphoinositide 3-kinase by Tyr kinases and Ras. J Biol Chem 2002; 277:41556-62.
4. Jones SM, Kazlauskas A. Growth-factor-dependent mitogenesis requires two distinct phases of signalling. Nat Cell Biol 2001; 3:165-72.
5. 1 is required for c-Myc stabilization and S phase entry. Mol Cell Biol 2006; 26:9116-25.
6. Stacey D, Kazlauskas A. Regulation of Ras signaling by the cell cycle. Curr Opin Genet Dev 2002; 12:44-46.
7. Dang CV. c-Myc target genes involved in cell growth, apoptosis and metabolism. Mol Cell Biol 1999; 19:1-11.
8. Kip1 is abrogated by c-Myc. EMBO J 1996; 15:6595-604.
9. Mateyak MK, Obaya AJ, Sedivy JM. c-Myc regulates Cyclin D-Cdk4 and Cdk6 activity but affects cell cycle progression at multiple independent points. Mol Cell Biol 1999; 19:4672-83.
10. 1/S transition in mouse ES cells. Oncogene 2002;21:5515-28. Oncogene 2002; 5515-28.
11. Littlewood TD, Hancock DC, Danielian PS, Parker MG, Evan GI. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res 1995; 23:1686-90.
12. Eilers M, Schirm S, Bishop JM. The MYC protein activates transcription of the alpha-prothymosin gene. EMBO J 1991; 10:133-41.
13. 1 transition in nontransformed cells. Cell Growth Differ 1993; 4:93-104.
14. Bouchard C, Marquardt J, Bras A, Medema RH, Eilers M. Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins. EMBO J 2004; 23:2830-40.
15. Bowman T, Broome MA, Sinibaldi D, Wharton W, Pledger WJ, Sedivy JM, Irby R, Yeatman T, Courtneidge SA, Jove R. Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis. Proc Natl Acad Sci USA 2001; 98:7319-24.
16. Kerkhoff E, Houben R, Löffler S, Troppmair J, Lee JE, Rapp UR. Regulation of c-myc expression by Ras/Raf signalling. Oncogene 1998; 16:211-16.
17. Matsumura I, Tanaka H, Kanakura Y. E2F1 and c-myc in cell growth and death. Cell Cycle 2003; 2:333-38.
18. Ponzielli R, Katz S, Barsyte-Lovejoy D, Penn LZ. Cancer therapeutics: Targeting the dark side of Myc. Eur J Cancer 2005; 41:2485-501.
19. Sears RC. The life cycle of C-Myc. Cell cycle 2004; 3:1133-37.
20. Hemann MT, Bric A, Teruya-Feldstein J, Herbst A, Nilsson JA, Cordon-Cardo C, Cleveland JL, Tansey WP, Lowe SW. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants. Nature 2005; 436:807-11.
21. Vivanco I, Sawyers CL. The PI3K AKT pathway in human cancer. Nat Rev Cancer 2002; 2:489-501.
22. Jimenez C, Portela RA, Mellado M, Rodriguez-Frade JM, Collard J, Serrano A, Martinez-A C, Avila J, Carrera AC. Role of the PI3K regulatory subunit in the control of Actin organization and cell migration. J Cell Biol 2000; 151:249-62.
23. Álvarez B, Martínez AC, Burgering BM, Carrera AC. Forkhead transcription factors contribute to execution of the mitotic programme in mammals. Nature 2001; 413:744-47.
24. Álvarez B, Garrido F, Garcia-Sanz JA, Carrera AC. PI3K activation regulates cell division time by coordinated control of cell mass and cell cycle progression rate. J Biol Chem 2003; 278:26466-73.
25. Shtivelman E, Sussman J, Stokoe D. A role for PI3K and PKB activity in the G2/M phase of the cell cycle. Curr Biol 2002; 12:919-24.
26. Dangi S, Cha H, Shapiro P. Requirement for PI3K activity during progression through S-phase and entry into mitosis. Cell Signal 2003; 15:667-75.
27. Garcia Z, Silio V, Marques M, Cortes I, Kumar A, Hernandez C, Checa AI, Serrano A, Carrera AC. A PI3K activity-independent function of p85 regulatory subunit in control of mammalian cytokinesis. EMBO J 2006; 25:4740-51.
28. Caviston JP, Longtine M, Pringle JR, Bi E. The role of Cdc42p GTPase-activating proteins in assembly of the Septin ring in yeast. Mol Biol Cell 2003; 14:4051-66.
29. Kinoshita M. The Septins. Genome Biol 2003; 4:236-45.
30. Yasuda S, Oceguera-Yanez F, Kato T, Okamoto M, Yonemura S, Terada Y, Ishizaki T, Narumiya S. Cdc42 and mDia3 regulate microtubule attachment to kinetocores. Nature 2004; 428:767-771.
31. Spiliotis ET, Kinoshita M, Nelson WJ. A mitotic Septin scaffold required for Mammalian chromosome congression and segregation. Science 2005; 307:1781-85.
32. Yoshizaki H, Ohba Y, Kurokawa K, Itoh RE, Nakamura T, Mochizuki N, Nagashima K, Matsuda M. Activity of Rho-family GTPases during cell division as visualized with FRET-based probes. J Cell Biol 2003; 162:223-32.
33. Oceguera-Yanez F, Kimura K, Yasuda S, Higashida C, Kitamura T, Hiraoka Y, Haraguchi T, Narumiya S. Ect2 and MgcRacGAP regulate the activation and function of Cdc42 in mitosis. J Cell Biol 2005; 168:221-232.
34. Surka MC, Tsang CW, Trimble WS. The mammalian Septin MSF localizes with microtubules and is required for completion of cytokinesis. Mol Biol Cell 2002; 13:3532-45.
35. Kinoshita M, Kumar S, Mizoguchi A, Ide C, Kinoshita A, Haraguchi T, Hiraoka Y, Noda M. Nedd5, a mammalian Septin, is a novel cytoskeletal component interActing with Actin-based structures. Genes Dev 1997; 11:1535-47.
36. Morita K, Hirono K, Han M. The Caenorhabditis elegans ect-2 RhoGEF gene regulates cytokinesis and migration of epidermal P cells. EMBO Rep 2005; 6:1163-68.
37. Mishima M, Kaitna S, Glotzer M. Central spindle assembly and cytokinesis require a kinesin-like protein/RhoGAP complex with microtubule bundling activity. Dev Cell 2002; 2:41-54.
38. Benink HA, Bement WM. Concentric zones of active RhoA and Cdc42 around single cell wounds. J Cell Biol 2005; 168:429-39.
39. Medema RH, Kops GJ, Bos JL, Burgering BM. AFX-like Forkhead TF mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 2000; 404:782-87.
40. 2 mRNA expression by forkhead transcription factors: Novel mechanism for cell cycle control by PI3K and forkhead. Mol Cell Biol 2004; 24:2181-89.
41. Yeh E, Cunningham M, Arnold H, Chasse D, Monteith T, Ivaldi G, Hahn WC, Stukenberg PT, Shenolikar S, Uchida T, Counter CM, Nevins JR, Means AR, Sears RA. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat Cell Biol 2004; 6:308-18.
42. van Weeren PC, de Bruyn KM, de Vries-Smits AM, van Lint J, Burgering BM. Essential role for PKB in insulin-induced GSK3 inactivation: Characterization of dominant-negative mutant of PKB. J Biol Chem 1998; 273:13150-56.
43. Ryves WJ, Harwood AJ. The interaction of glycogen synthase kinase-3 (GSK-3) with the cell cycle. Prog Cell Cycle Res 2003; 5:489-95.
44. 1-phase progression. Genes Dev 1999; 13:1501-12.